Home › Funds › STEMPOINT CAPITAL LP › CBIO
STEMPOINT CAPITAL LP position in CBIO
CRESCENT BIOPHARMA INC. · Health Care
STEMPOINT CAPITAL LP reported holding 182,382 shares of CBIO (CRESCENT BIOPHARMA INC.) in its Q2 2026 13F filing — a position valued at US$3.3M, representing 0.73% of its reported portfolio and ranking #45 among its reported holdings. STEMPOINT CAPITAL LP first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How STEMPOINT CAPITAL LP's CBIO position evolved
STEMPOINT CAPITAL LP first disclosed a stake in CBIO in Q2 2026 at 182,382 shares (US$3.3M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 182.38K | $3.28M | New |
About CBIO and 13F data
CBIO (CRESCENT BIOPHARMA INC.) is a Health Care company. 71 other funds we track also report a position in CBIO — the largest reported positions include BVF INC/IL (US$49.5M), Fairmount Funds Management LLC (US$49.5M), Venrock Adviser, LLC (US$38.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CBIO
- BVF INC/IL 2.75M sh · $49.48M · Q2 2026
- Fairmount Funds Management LLC 2.75M sh · $49.46M · Q2 2026
- Venrock Adviser, LLC 2.13M sh · $38.40M · Q2 2026
- Logos Global Management LP 1.90M sh · $34.20M · Q2 2026
- FCPM III SERVICES B.V. 1.68M sh · $30.20M · Q2 2026
- Vestal Point Capital, LP 1.63M sh · $29.34M · Q2 2026
- Opaleye Management Inc. 1.32M sh · $23.75M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 1.16M sh · $20.88M · Q2 2026
- Boxer Capital Management, LLC 453.69K sh · $8.17M · Q2 2026
- NEXTBio Capital Management LP 372.86K sh · $6.71M · Q2 2026
- Remedium Capital Partners, LLC 361.25K sh · $6.50M · Q2 2026
- Exome Asset Management LLC 127.77K sh · $2.30M · Q2 2026
More on STEMPOINT CAPITAL LP
FAQ
How long has STEMPOINT CAPITAL LP held CBIO?
STEMPOINT CAPITAL LP has disclosed CBIO holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is STEMPOINT CAPITAL LP's current position in CBIO?
As of Q2 2026, STEMPOINT CAPITAL LP holds 182.38K shares of CBIO (CRESCENT BIOPHARMA INC.), valued at $3.28M, representing 0.73% of its reported portfolio and ranking #45.
Has STEMPOINT CAPITAL LP been buying or selling CBIO?
In the latest 13F filing (Q2 2026), STEMPOINT CAPITAL LP newly opened its position in CBIO.
Which other funds hold CBIO?
Other major institutional holders of CBIO include BVF INC/IL, Fairmount Funds Management LLC, Venrock Adviser, LLC, among 71 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.